Ata Inc. ADR buy krebskrebs
Start price
09.09.20
/
50%
€0.90
Target price
04.11.21
€1.20
Performance (%)
128.89%
End price
05.11.21
€2.06
Summary
This prediction ended on 05.11.21 with a price of €2.06. With a performance of 128.89% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ata Inc. ADR | - | - | - | - |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
Comments by krebskrebs for this prediction
In the thread Ata Inc. ADR diskutieren
In the thread Trading Ata Inc. ADR
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten